Published in Gene Ther on January 01, 1994
Gene therapy: light is finally in the tunnel. Protein Cell (2012) 0.87
Promoter-regulatory region of the major immediate early gene of human cytomegalovirus. Proc Natl Acad Sci U S A (1984) 5.04
CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J Exp Med (2000) 3.62
Nucleotide sequences of herpes simplex virus type 1 (HSV-1) affecting virus entry, cell fusion, and production of glycoprotein gb (VP7). Virology (1982) 3.53
Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem (1994) 3.14
Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair. J Orthop Res (1998) 2.35
Metabolic mapping of functional activity in the hypothalamo-neurohypophysial system of the rat. Science (1979) 2.22
A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats. J Virol (1994) 1.86
Expression of a human cytomegalovirus late gene is posttranscriptionally regulated by a 3'-end-processing event occurring exclusively late after infection. Mol Cell Biol (1986) 1.78
Activity-dependent energy metabolism in rat posterior pituitary primarily reflects sodium pump activity. J Neurochem (1980) 1.73
Innovative materials processing strategies: a biomimetic approach. Science (1992) 1.72
Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus. Proc Natl Acad Sci U S A (1999) 1.68
HSV-mediated gene transfer of vascular endothelial growth factor to dorsal root ganglia prevents diabetic neuropathy. Gene Ther (2005) 1.63
Multicenter clinical and analytical evaluation of the AxSYM troponin-I immunoassay to assist in the diagnosis of myocardial infarction. Clin Chem (1999) 1.62
Competitive quantitative PCR analysis of herpes simplex virus type 1 DNA and latency-associated transcript RNA in latently infected cells of the rat brain. J Virol (1994) 1.51
Genome locations of temperature-sensitive mutants in glycoprotein gB of herpes simplex virus type 1. Virology (1984) 1.45
PCR-based analysis of herpes simplex virus type 1 latency in the rat trigeminal ganglion established with a ribonucleotide reductase-deficient mutant. J Virol (1994) 1.45
An X Window system for statlab results reporting. Proc Annu Symp Comput Appl Med Care (1993) 1.43
HSV trafficking and development of gene therapy vectors with applications in the nervous system. Gene Ther (2005) 1.42
Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion. Gene Ther (2001) 1.41
Some thoughts on the nature of ectopic parathyroid hormones. Am J Med (1971) 1.39
Two herpes simplex virus type 1 latency-active promoters differ in their contributions to latency-associated transcript expression during lytic and latent infections. J Virol (1995) 1.37
Gene transfer to interfere with TNFalpha signaling in neuropathic pain. Gene Ther (2007) 1.37
Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons. Gene Ther (1998) 1.36
Gene transfer to neurons using herpes simplex virus-based vectors. Annu Rev Neurosci (1996) 1.35
The effect of ammonium chloride and tunicamycin on the glycoprotein content and infectivity of herpes simplex virus type 1. Virology (1983) 1.34
Early events in herpes simplex virus type 1 infection: photosensitivity of fluorescein isothiocyanate-treated virions. Proc Natl Acad Sci U S A (1981) 1.29
In vivo metabolism of complement. I. Metabolism of the third component (C'3) in acquired hemolytic anemia. J Clin Invest (1969) 1.26
HSV-mediated transfer of interleukin-10 reduces inflammatory pain through modulation of membrane tumor necrosis factor alpha in spinal cord microglia. Gene Ther (2007) 1.22
Biomineralization and eggshells: cell-mediated acellular compartments of mineralized extracellular matrix. Int Rev Cytol (1993) 1.22
Development and application of herpes simplex virus vectors for human gene therapy. Annu Rev Microbiol (1995) 1.22
Requirements for activation of the herpes simplex virus glycoprotein C promoter in vitro by the viral regulatory protein ICP4. J Virol (1994) 1.22
Herpes simplex virus type 1 ICP0 protein does not accumulate in the nucleus of primary neurons in culture. J Virol (2000) 1.20
Activation of human immunodeficiency virus by herpes simplex virus. J Infect Dis (1992) 1.13
Replication-defective herpes simplex virus vectors for gene transfer in vivo. Proc Natl Acad Sci U S A (1996) 1.12
Seasonal enumeration of fecal coliform bacteria from the feces of ring-billed gulls (Larus delawarensis) and Canada geese (Branta canadensis). Appl Environ Microbiol (1999) 1.12
In vivo expression of beta-galactosidase in hippocampal neurons by HSV-mediated gene transfer. Hum Gene Ther (1992) 1.11
Serum cholesterol and primary brain tumours: a case-control study. Int J Epidemiol (1989) 1.11
Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications. Gene Ther (1998) 1.08
Herpes simplex virus type 1 ICP4 promotes transcription preinitiation complex formation by enhancing the binding of TFIID to DNA. J Virol (2000) 1.08
Rapid method for construction of recombinant HSV gene transfer vectors. Gene Ther (1997) 1.06
Detection of herpes simplex virus type 1 latency-associated transcript expression in trigeminal ganglia by in situ reverse transcriptase PCR. J Virol (1996) 1.06
Herpes simplex virus RNAi and neprilysin gene transfer vectors reduce accumulation of Alzheimer's disease-related amyloid-beta peptide in vivo. Gene Ther (2006) 1.06
Prolonged preservation of nerve function in diabetic neuropathy in mice by herpes simplex virus-mediated gene transfer. Diabetologia (2007) 1.05
Oligomer formation of the gB glycoprotein of herpes simplex virus type 1. J Virol (1991) 1.02
Autoimmune thyroiditis and exposure to iodine 131 in the Ukrainian cohort study of thyroid cancer and other thyroid diseases after the Chornobyl accident: results from the first screening cycle (1998-2000). J Clin Endocrinol Metab (2006) 1.01
Pseudotyping of glycoprotein D-deficient herpes simplex virus type 1 with vesicular stomatitis virus glycoprotein G enables mutant virus attachment and entry. J Virol (2000) 0.98
Rapid construction of deleted DNA fragments for use as internal standards in competitive PCR. PCR Methods Appl (1994) 0.98
Differential distribution of (Na, K)-ATPase alpha isoforms in the central nervous system. Cell Mol Neurobiol (1991) 0.97
Engineering herpes simplex virus vectors for CNS applications. Exp Neurol (1999) 0.97
S100 is preferentially distributed in myelin-forming Schwann cells. J Neurocytol (1990) 0.97
HveC (nectin-1) is expressed at high levels in sensory neurons, but not in motor neurons, of the rat peripheral nervous system. J Neurovirol (2001) 0.95
A human trial of HSV-mediated gene transfer for the treatment of chronic pain. Gene Ther (2009) 0.95
Herpes simplex virus type 1 vector-mediated expression of nerve growth factor protects dorsal root ganglion neurons from peroxide toxicity. J Virol (1999) 0.95
Intermolecular interactions in collagen self-assembly as revealed by Fourier transform infrared spectroscopy. Science (1983) 0.94
Gene therapy of bladder pain with herpes simplex virus (HSV) vectors expressing preproenkephalin (PPE). Urology (2001) 0.93
Epidemiologic factors affecting antimicrobial resistance of common bacterial isolates. J Clin Microbiol (1987) 0.93
Gene therapy progress and prospects: Parkinson's disease. Gene Ther (2003) 0.93
Prevalence of use of cocaine and other substances in an obstetric population. Am J Obstet Gynecol (1990) 0.92
Cytochemical localization of Ca2+-ATPase activity in peripheral nerve. Brain Res (1988) 0.92
Resistance of herpes simplex virus type 2 to neomycin maps to the N-terminal portion of glycoprotein C. J Virol (1993) 0.92
Phosphorylation-dependent neurofilament epitopes are reduced at the node of Ranvier. J Neurocytol (1992) 0.92
Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA-induced degeneration. Exp Neurol (2001) 0.92
Herpes simplex virus vector-mediated expression of Bcl-2 prevents 6-hydroxydopamine-induced degeneration of neurons in the substantia nigra in vivo. Proc Natl Acad Sci U S A (1999) 0.92
Herpes simplex virus vector-mediated gene delivery of glutamic acid decarboxylase reduces detrusor overactivity in spinal cord-injured rats. Gene Ther (2009) 0.91
Abnormalities of sodium handling and of cardiovascular adaptations during high salt diet in patients with mild heart failure. Circulation (1993) 0.91
Immunocytochemical demonstration of Na+,K(+)-ATPase in internodal axolemma of myelinated fibers of rat sciatic and optic nerves. J Neurochem (1991) 0.91
The avian eggshell extracellular matrix as a model for biomineralization. Connect Tissue Res (1996) 0.91
Factors associated with identifying tuberculosis contacts. Int J Tuberc Lung Dis (2003) 0.89
Connexin 43-enhanced suicide gene therapy using herpesviral vectors. Mol Ther (2000) 0.89
Herpes simplex virus vector-mediated delivery of glial cell line-derived neurotrophic factor rescues erectile dysfunction following cavernous nerve injury. Gene Ther (2007) 0.89
MR imaging of brachial plexopathy in neurolymphomatosis. AJR Am J Roentgenol (1997) 0.89
Differential distribution of (Na,K)-ATPase alpha isoform mRNAs in the peripheral nervous system. Brain Res (1991) 0.88
The high mobility group protein 1 is a coactivator of herpes simplex virus ICP4 in vitro. J Virol (1998) 0.88
Genetic analysis of type-specific antigenic determinants of herpes simplex virus glycoprotein C. J Virol (1992) 0.88
Disease pattern recognition testing for rheumatoid arthritis using infrared spectra of human serum. Clin Chim Acta (2001) 0.88
Serum cholesterol levels in adenomatous polyps and cancer of the colon. A case-control study. JAMA (1986) 0.87
Cerebral atrophy in young cannabis smokers. Lancet (1972) 0.86
Genetic studies exposing the splicing events involved in herpes simplex virus type 1 latency-associated transcript production during lytic and latent infection. J Virol (1999) 0.86
Changes in intra-axonal calcium distribution following nerve crush. J Neurobiol (1986) 0.86
Cancer overview. Cancer Res (1979) 0.85
Distribution of albumin-like immunoreactivity in rat sciatic nerve after nerve crush injury. J Neuropathol Exp Neurol (1988) 0.85
Retrograde axonal transport of endogenous proteins in sciatic nerve demonstrated by covalent labeling in vivo. Science (1980) 0.84
Multiple applications for replication-defective herpes simplex virus vectors. Stem Cells (2001) 0.83
Transgene-mediated expression of tumor necrosis factor soluble receptor attenuates morphine tolerance in rats. Gene Ther (2011) 0.83
Axotomy increases CNTF receptor mRNA in rat spinal cord. Brain Res (1993) 0.83
cis-acting elements involved in transcriptional regulation of the herpes simplex virus type 1 latency-associated promoter 1 (LAP1) in vitro and in vivo. J Virol (1996) 0.83
Ultrastructural distribution of Ca++ within neurons. An oxalate pyroantimonate study. Histochemistry (1987) 0.83
Expression of HSV-1 receptors in EBV-associated lymphoproliferative disease determines susceptibility to oncolytic HSV. Gene Ther (2012) 0.82
Single chain ferritin chimera as an improved MRI gene reporter. Prilozi (2010) 0.82
The use of a labeled acylating probe for the study of fast axonal transport, in vivo. Brain Res (1979) 0.82
Effect of herpes simplex virus vector-mediated interleukin-4 gene therapy on bladder overactivity and nociception. Gene Ther (2012) 0.82
Prolonged regulatable expression of EPO from an HSV vector using the LAP2 promoter element. Gene Ther (2011) 0.82
Herpes simplex virus type 1 vector mediated gene transfer to muscle. Gene Ther (1995) 0.82
A direct electron microscopic immunocytochemical study of IgM paraproteinemic neuropathy. Arch Neurol (1988) 0.82
Herpes simplex virus vectors for gene transfer to the nervous system. J Neurovirol (1997) 0.81